EUVIMEDEUVIMED entdecken
Crossref

Association Between the Expression of PD-L1 and the Therapeutic Efficacy of Osimertinib in EGFR-mutated Non-small Cell Lung Cancer

Keisuke Shiraha, Hiromi Watanabe, Mayu Goda, Suzuka Matsuoka, Yuki Takigawa, Jun Nishimura, Kenichiro Kudo, Ken Sato, Keiichi Fujiwara, Takuo Shibayama

Haigan · 20.04.2026 · 66 (2) · 49-54

DOI: 10.2482/haigan.66.49 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Haigan, erschienen am 20.04.2026. Verfasst von Keisuke Shiraha und 9 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Shiraha, K., Watanabe, H., Goda, M., Matsuoka, S., Takigawa, Y., Nishimura, J., Kudo, K., Sato, K., Fujiwara, K., & Shibayama, T. (2026). Association Between the Expression of PD-L1 and the Therapeutic Efficacy of Osimertinib in EGFR-mutated Non-small Cell Lung Cancer. Haigan, 66(2), 49-54. https://doi.org/10.2482/haigan.66.49

Vancouver

Shiraha K, Watanabe H, Goda M, Matsuoka S, Takigawa Y, Nishimura J, et al. Association Between the Expression of PD-L1 and the Therapeutic Efficacy of Osimertinib in EGFR-mutated Non-small Cell Lung Cancer. Haigan. 2026;66(2):49-54. doi:10.2482/haigan.66.49

BibTeX
@article{Shiraha2026,
  author = {Shiraha, Keisuke and Watanabe, Hiromi and Goda, Mayu and Matsuoka, Suzuka and Takigawa, Yuki and Nishimura, Jun and Kudo, Kenichiro and Sato, Ken and Fujiwara, Keiichi and Shibayama, Takuo},
  title = {Association Between the Expression of PD-L1 and the Therapeutic Efficacy of Osimertinib in EGFR-mutated Non-small Cell Lung Cancer},
  journal = {Haigan},
  year = {2026},
  volume = {66},
  number = {2},
  pages = {49--54},
  doi = {10.2482/haigan.66.49}
}
Kostenlos starten →